Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $2.75, $0.22 better than the analyst estimate of $2.53. Revenue for the quarter came in at $528.1 million versus the consensus estimate of $528.41 million.

GUIDANCE:

Medpace Holdings sees FY2024 EPS of $11.24-$11.93, versus the consensus of $11.46. Medpace Holdings sees FY2024 revenue of $2.125-2.175 billion, versus the consensus of $2.17 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.